CLINICAL_TRIALS
trial_result
· 2022-05-04
Clinical Trial Update: Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder [Phase 2, Phase 3]
Summary
A Clinical Trials update reports safety and efficacy data for fecal microbiota transplantation in bipolar depression, spanning Phase 2 and Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Valerie Taylor | Conditions: Bipolar Depression | Phase 2, Phase 3 | Status: UNKNOWN